Learning Objectives:

• Describe basic principles of Addiction Medicine and related epidemiology
• Review substance use disorders (SUDs) commonly encountered in the inpatient Internal Medicine setting
• Describe the various form of Medication Assisted Treatment (MAT) and the related pharmacology
• Discuss the nuances and challenges of treating the acute ill patient comorbid substance use disorders.

Listed below are individuals with control of the content of this program who have disclosed...
No relevant financial relationship(s) with industry:

Planning Committee:

Andy Herber PA-C – None
Abigail Meyers, PA-C – None
Elizabeth Nelson, APRN, CNP – None
Dr. Jamie Newman – None
Kyle Satterblom, PA-C – None
Amy Van Hoof – None

Dr. Robert Kirchoff - None

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:

• Buprenorphine
• Gabapentin
• Propranolol
• Clonidine

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here. 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.